Beranda › Tumor Otak › New York
Uji klinis Tumor Otak di New York
35 studi untuk Tumor Otak mencari peserta di lokasi di New York.
Kota di New York
Teks studi resmi (Bahasa Inggris)
Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma
- New York University Langone's Perlmutter Cancer Institute, New York
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06991101Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- Northwell Health Center for Advanced Medicine - Brain Tumor Center, Lake Success
- Columbia University Irving Medical Center, New York
- Montefiore Medical Center, The Bronx
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07326566Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Memorial Sloan Kettering Cancer Center, New York
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT05786924A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Local Institution - 0142, Buffalo
- Local Institution - 0170, New York
- Memorial Sloan Kettering Cancer Center, New York
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07492680A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Icahn School of Medicine at Mount Sinai, New York
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT06253871A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- Memorial Sloan-Kettering Cancer Center, New York
- Mayo Clinic_Rochester, Rochester
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT07428616A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
- Stony Brook Cancer Center, Stony Brook
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT06764940Phase I Study of Fractionated Stereotactic Radiation Therapy
- Montefiore Medical Center, The Bronx
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT03726359Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- Albany Medical Center, Albany
- SUNY Upstate Medical Center, Syracuse
- Montefiore Einstein, The Bronx
- dan 1 lainnya
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT04427384Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- Roswell Park Cancer Institute, Buffalo
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 21 Jul 2026 · NCT04348747Chronic CED of TPT for Recurrent Malignant Glioma
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jun 2026 · NCT06666712A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain
- Memorial Sloan Kettering Suffolk - Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- dan 1 lainnya
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Jun 2026 · NCT05419076Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
- State University of New York Upstate Medical University, Syracuse
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Jun 2026 · NCT03550391CONVIVO Endomicroscopy
- Northwell Health, Manhasset
Menerima pesertaSukarelawan sehat diterima
Semua usia · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT06087393European Prospective Investigation Into Childhood Cancer
- Columbia University Irving Medical Center, New York
Menerima pesertaStudi observasional
Usia 3 hingga 21 · Semua jenis kelamin · Diperbarui 2 Jun 2026 · NCT05375617Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
- Lenox Hill Brain Tumor Center, New York
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Jun 2026 · NCT05954858Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
- Lenox Hill Brain Tumor Center, New York
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Jun 2026 · NCT05271240Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- Lenox Hill Brain Tumor Center, New York
Menerima pesertaFase 1/2
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 1 Jun 2026 · NCT03213002Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
- Lenox Hill Brain Tumor Center, New York
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Jun 2026 · NCT05979064Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- Lenox Hill Brain Tumor Center, New York
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Jun 2026 · NCT02861898A Study of Sotorasib in People With Brain Tumors
- Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering West Harrison (Limited Protocol Activities), Harrison
- dan 2 lainnya
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Mei 2026 · NCT06807619Brodalumab in the Treatment of Immune-Related Adverse Events
- Columbia University Irving Medical Center, New York
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Mei 2026 · NCT06673329Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
- State University of New York, Downstate, Brooklyn
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Hingga usia 18 · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT04322734rTMS for Postoperative Brain Tumor Patients
- Columbia University Irving Medical Center, New York
Menerima peserta
Usia 22 hingga 65 · Semua jenis kelamin · Diperbarui 15 Apr 2026 · NCT07530536Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT06810544Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- Lenox Hill Brain Tumor Center, New York
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT02800486Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- Weill Cornell Medicine, New York
- Brooklyn Methodist Hospital - NewYork Presbyterian, New York
- New York Presbyterian Hospital - Queens, New York
Menerima pesertaFase 1/2
Usia 19 hingga 90 · Wanita · Diperbarui 30 Mar 2026 · NCT03449238Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mar 2026 · NCT05559853Trastuzumab Deruxtecan (T-DXd) for People With Brain Cancer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Feb 2026 · NCT06058988FUS Etoposide for DMG
- Columbia University Irving Medical Center, New York
Menerima pesertaFase 1
Usia 4 hingga 21 · Semua jenis kelamin · Diperbarui 28 Jan 2026 · NCT05762419Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling
- University of Rochester, Rochester
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Des 2025 · NCT04965064Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
- New York-Presbyterian/Weill Cornell Medical Center, New York
Menerima pesertaFase 4
Usia 18 ke atas · Wanita · Diperbarui 24 Nov 2025 · NCT06072807Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
- Memorial Sloan Kettering Cancer Center, New York
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Okt 2025 · NCT00870129S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Nyack Hospital, Nyack
- Dickstein Cancer Treatment Center, White Plains
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Okt 2025 · NCT03418961Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- Northshore University Hospital, Manhasset
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Mar 2025 · NCT01906385Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.